L E DeLanney - JoVE Visualize

Showing results (31-40 of 43) with videos related to

Pageof 5

Sort By:

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1992

Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineR Moratalla, B Quinn, L E DeLanney, et al.

Brain Research|June 26, 1989

Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamineG A Ricaurte, L E DeLanney, I Irwin, et al.

European Journal of Pharmacology|June 4, 1987

3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brainG A Ricaurte, K F Finnegan, D E Nichols, et al.

Brain Research|February 10, 1987

Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigraG A Ricaurte, I Irwin, L S Forno, et al.

Brain Research|June 18, 1986

Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessmentG A Ricaurte, J W Langston, L E Delanney, et al.

Journal of Neurochemistry|June 1, 1994

Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicityP Chan, D A Di Monte, J J Luo, et al.

Brain Research|October 29, 1990

The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkeyI Irwin, L E DeLanney, L S Forno, et al.

JAMA|July 1, 1988

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primatesG A Ricaurte, L S Forno, M A Wilson, et al.

European Journal of Pharmacology|September 4, 1990

Modulating role of dopamine on anesthetic requirementsI S Segal, J K Walton, I Irwin, et al.

Brain Research|October 28, 1996

Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeysD A Di Monte, L E DeLanney, I Irwin, et al.

Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:

Pageof 5

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1992

Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineR Moratalla, B Quinn, L E DeLanney, et al.

Brain Research|June 26, 1989

Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamineG A Ricaurte, L E DeLanney, I Irwin, et al.

European Journal of Pharmacology|June 4, 1987

3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brainG A Ricaurte, K F Finnegan, D E Nichols, et al.

Brain Research|February 10, 1987

Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigraG A Ricaurte, I Irwin, L S Forno, et al.

Brain Research|June 18, 1986

Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessmentG A Ricaurte, J W Langston, L E Delanney, et al.

Journal of Neurochemistry|June 1, 1994

Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicityP Chan, D A Di Monte, J J Luo, et al.

Brain Research|October 29, 1990

The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkeyI Irwin, L E DeLanney, L S Forno, et al.

JAMA|July 1, 1988

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primatesG A Ricaurte, L S Forno, M A Wilson, et al.

European Journal of Pharmacology|September 4, 1990

Modulating role of dopamine on anesthetic requirementsI S Segal, J K Walton, I Irwin, et al.

Brain Research|October 28, 1996

Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeysD A Di Monte, L E DeLanney, I Irwin, et al.

Pageof 5